| Breitenstein, Urs (Nemis Technologies 202202 CFO + Co-Founder) |
Chief Financial Officer (CFO) |
Nemis Technologies AG |
Switzerland |
| Bremer, Ralf (Gerstel 201402 Managing Director, RnD + Production) |
Managing Director |
Gerstel (Group) |
Germany |
| Brenker, Kathrin (Opto Biolabs 201906– Managing Director + Founder) |
Managing Director |
Opto BIolabs GmbH (formerly UG) |
Germany |
| Brennan, John (EuropaBio –201808 Secretary General LEFT 9/18) |
lobbying |
EuropaBio aisbl – the European Association of Bioindustries |
Belgium |
| Brennecke, Marcus (EQT Partners 201706 Partner + Investment Advisor to EQT VII fund) |
Partner (venture partner) |
EQT (Wallenberg family) (Group) |
|
| Brennecke, Thomas (Staatz Business Development & Strategy) |
consulting (economic) |
Staatz Business Development & Strategy – Dr. Irina Staatz-Granzer |
Germany |
| Brenning, Thomas |
n. a. |
Helaba (Group) |
Germany |
| Bresch, Heather (Mylan 201310 CEO) |
Chief Executive Officer (CEO) |
Mylan (Group) |
United States (USA) |
| Bressi, Jeanette (MorphoSys 202012 Director US Communications) |
Public Relations Manager / Investor Relations Manager |
MorphoSys (Group) |
United States (USA) |
| Brett, Catherine (Innovative Medicines Initiative 201807 External Relations Manager) |
President/Director/Head Business Group/Unit/Division |
Innovative Medicines Initiative (IMI + IMI2) |
EU (European Union) |
| Brett, Gerard (Vivasure Medical 201609 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Vivasure Medical Ltd. |
Ireland, Republic of |
| Breu, Jessica (Immunic 201904 Manager IR + Communications) |
Public Relations Manager / Investor Relations Manager |
Immunic (Group) |
Germany |
| Breu, Raymund (Novartis –2001003 CFO retires 3/10) |
Chief Financial Officer (CFO) |
Novartis (Group) |
Switzerland |
| Breuer, Sebastian (Genetics Company 200608 Program Manager Diagnostics) |
Product Manager (personnel) |
Genetics Company Inc., The |
Switzerland |
| Breugelmans, Matthias (Elastrin 202209 CEO) |
Chief Executive Officer (CEO) |
Elastrin Therapeutics |
|
| Breuker, Kathrin (Univ Innsbruck 201005 Principal Investigator Institute of Organic Chemistry) |
Researcher (university / research institute) |
University of Innsbruck |
Austria |
| Brewis, Neil (F-Star 201611 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Sino Biopharm (Group) |
United Kingdom (GB) |
| Brichard, Vincent (Life Sciences Partners 2016– Venture Partner before GSK SVP + Head of Immunotherapeutics) |
Partner (venture partner) |
EQT (Wallenberg family) (Group) |
Netherlands |
| Brickwedde, Fritz (DBU 200501) |
n. a. |
Deutsche Bundesstiftung Umwelt DBU |
Germany |
| Briel, Andreas (NanoPET Pharma GmbH 201412 Managing Director) |
Managing Director |
NanoPET Pharma GmbH |
Germany |
| Brilling, Julia (Norgenta 201211 Project Manager Industrial Cell Technology) |
Cluster Manager |
Hamburg (govt region) |
Germany |
| Brinke-Seiferth, Stephan (i3 Membrane GmbH 201306– Managing Director + Founder) |
Managing Director |
i3 membrane GmbH |
Germany |
| Brinkhaus, Franck (Biotech Alliances International Inc 201810 CEO before Woodside Capital Partners) |
Chief Executive Officer (CEO) |
Biotech Alliances International Inc. |
United States (USA) |
| Brinkhoff, Günter |
n. a. |
BioAgency AG |
Germany |
| Brinkmann, Klaus (Curetis 201112– Director of Sales before Bio-Rad (DE) + Becton Dickinson GmbH + Beckman Coulter GmbH) |
Sales Manager / Marketing Manager |
OpGen (Group) |
Germany |
| Brinkmann, Thomas (Unilabs 201306 CMO) |
Chief Medical Officer (CMO) |
Unilabs (Group) |
Denmark |
| Brinzey, Christopher F. (Chris) (Westwicke Partners 201703) |
Public Relations Manager / Investor Relations Manager |
ICR (Group) |
United States (USA) |
| Brister, David (Evotec 200609– before MVM Ltd before 3i before Metal Box plc) |
n. a. |
Evotec (Group) |
Germany |
| Britten, Cedrik (Immatics 202006– CMO before GSK VP + Head of Oncology Cell Therapy Research Unit + BioNTech) |
Chief Medical Officer (CMO) |
Immatics (Group) |
Germany |
| Brix, Klaudia (Jacobs Univ Bremen 201104 Professor of Cell Biology) |
Professor |
Schaffhausen Institute of Technology (SIT) |
Germany |
| Brkulj, Mario (MacDougall 201511 VP before MorphoSys + Biocom) |
Public Relations Manager / Investor Relations Manager |
MacDougall Biomedical Communications Inc. (MBI) |
Germany |
| Brock, Stephan (Molecular Health 201401 CEO of European division before Metalife + LION Bioscience) |
Chief Executive Officer (CEO) |
Molecular Health (Group) |
Germany |
| Brockhoff, Gero (Univ Regensburg 2006 Institute for Pathology) |
Researcher (university / research institute) |
University of Regensburg, Institute for Pathology (IPUR) |
Germany |
| Brockmeyer, Carsten (Formycon 201305 CEO) |
Chief Executive Officer (CEO) |
Formycon (Group) |
Germany |
| Brodard, Lionel (MedXCell 202106 CFO) |
Chief Financial Officer (CFO) |
MedXCell (Group) |
Switzerland |
| Brodbeck, Sonja (co:bios Technologiezentrum 201104 Managing Director) |
Managing Director |
co:bios Technologiezentrum GmbH |
Germany |
| Brodkorb, Mathias (Mecklenburg-Vorpommern (govt) 201312 Minister for Education + Science) |
Minister |
Mecklenburg-Vorpommern (govt region) |
Germany |
| Broer, Wim (Cotecna 201712 Manager Developm + Science at NofaLab) |
n. a. |
Cotecna (Group) |
Netherlands |
| Bronsema, Viola (BIO Deutschland 200905 Managing Director + CureVac 202008– Supervisory Board Member) |
Managing Director |
BIO Deutschland e. V. |
Germany |
| Brooke, Paul (venBio 201204 Partner before Morgan Stanley) |
Partner (venture partner) |
VenBio (Group) |
United States (USA) |
| Broom, Colin (Nabriva 201409– CEO before ViroPharma CSO) |
Chief Executive Officer (CEO) |
Nabriva (Group) |
Austria |
| Brosch, Markus (Genedata 201905 Business Unit Head for Genedata Expressionist) |
Product Manager (personnel) |
Genedata (Group) |
Switzerland |
| Brosnan, Michael (Fresenius Medical Care 201804 CFO + proposed to MorphoSys Supervisory Board) |
Chief Financial Officer (CFO) |
Fresenius (Group) |
Germany |
| Brossmer, Reinhard (SialoTec GmbH 201601– Managing Director) |
Managing Director |
SialoTec GmbH |
Germany |
| Brouillon, Carinne (Boehringer Ingelheim 201911 Head of Global Therapeutic Areas) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Brown, Colin (Roche 201112 Head of Roche Professional Diagnostics) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
| Brown, Gregory B. (Cowen 201206 Managing Director of Cowen Royalty) |
Managing Director |
Cowen (Group) |
United States (USA) |
| Brown, Paul (Roche 201103 Head Roche Molecular Diagnostics) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
| Brown, Shaun (MC Services 201603) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Brown, Stephanie (Santhera 202112– President North America + Executive Board Member before Ipsen US + Novartis US) |
Board member, executive |
Santhera (Group) |
United States (USA) |
| Browning, Rod (Xradia 201306 CEO) |
Chief Executive Officer (CEO) |
Carl Zeiss (Group) |
United States (USA) |
| Bruce, Michael (Exo Therapeutics 202012 CEO) |
Chief Executive Officer (CEO) |
Exo Therapeutics Inc. |
United States (USA) |
| Bruch, Jens (Italy (govt) 201603 ICE German Office) |
Administrative Officer (personnel) |
Italy (govt) |
Germany |
| Bruchmann, Andreas (Axel Semrau 202111 Managing Director) |
Managing Director |
Trajan (Group) |
Germany |
| Bruchmann, Dietrich (Nuvisan 2022 Managing Director of Nuvisan Pharma Holding GmbH) |
Managing Director |
Nuvisan (Group) |
Germany |
| Bruchmann, Friderike (XO Life 202202 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
XO Life GmbH |
Germany |
| Bruderer, Roland M. (Biognosys 201601 Senior Scientist Mass Spectrometry) |
mass spectrometry (MS) |
Biognosys AG |
Switzerland |
| Brudnick, Richard (Codiak BioSciences 201902 CBO + Head of Strategy before Bioverativ + Biogen + Bain & Co) |
Business Development Manager / Strategy Manager |
Codiak BioSciences Inc. |
United States (USA) |
| Bruellhoff, Kristina (PS Biotech GmbH 201305 Managing Director + Co-Founder) |
Managing Director |
PS Biotech GmbH |
Germany |
| Bruhn, Heiko (Mediatum 201209 Managing Director of Mediatum Schweiz GmbH) |
Managing Director |
Mediatum (Group) |
Switzerland |
| Bruinsma, Gosse B. (IDEA 201002– CEO before Axonyx 200606 CEO) |
Chief Executive Officer (CEO) |
IDEA AG |
Germany |
| Brummelkamp, Thijn (Haplogen 2010– Founder) |
Company Founder |
Haplogen Bioscience GmbH |
Austria |
| Brun, Virginie (PX'Therapeutics 201008– CSO + co-founder of Promise Advanced Proteomics) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Aguettant (Group) |
France |
| Bruncko, Martin (EU (govt) 202201 Member of EIC Fund Investment Committee) |
Investment Manager |
EU (govt) |
EU (European Union) |
| Brunel, David (Biodesix 200810 CEO) |
Chief Executive Officer (CEO) |
Biodesix Inc. |
United States (USA) |
| Brunken, Heiko (Hochschule Bremen 201303 Professor for Ecology + Environmental Protection) |
Professor |
University of Applied Sciences Bremen (Hochschule Bremen) |
Germany |
| Brunner, Eduard M. (Creoptix 201909 Board Chairman) |
Board member, non-executive |
Spectris (Group) |
Switzerland |
| Brunner, H. |
n. a. |
Fraunhofer (Group) |
Germany |
| Brunner, Thomas (BioTek Instruments GmbH 200704 CEO) |
Chief Executive Officer (CEO) |
Agilent (Group) |
Germany |
| Brunnhuber, Barbara (Mireca Medicines 202204 CEO) |
Chief Executive Officer (CEO) |
Mireca Medicines GmbH |
Germany |
| Bruno, Michael (Crosshair Therapeutics 202201 CEO + Founder) |
Chief Executive Officer (CEO) |
Crosshair Therapeutics Inc. |
United States (USA) |
| Bruno-Raimondi, Alfredo E. (Freibiotics 201012 Managing Director) |
Managing Director |
Freibiotics GmbH |
Germany |
| Bruns, Ingmar (Pieris 201710– VP Clinical Development before Bayer Pharmaceutical since 2013) |
Clinical Research Manager |
Pieris (Group) |
United States (USA) |
| Bruns, Olaf (Kompass Private Equity 200710– Managing Director before 3i Group before Arthur Andersen) |
Managing Director |
Kompass (Group) |
Germany |
| Bruns, Stefan (Polyplan GmbH 200902 Managing Director) |
Managing Director |
Polyplan (Group) |
Germany |
| Brunswiek, Soenke (PharmCell 201501 Director Business Development) |
Business Development Manager / Strategy Manager |
Lonza (Group) |
Netherlands |
| Brusdeilins, Martin (Tecan 201109–201409 RETIRED 9/14 before Ortho-Clinical Diagnostics + Roche Diagnostics) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Tecan (Group) |
Switzerland |
| Bruss, Marina (BioTek Instruments GmbH 200809) |
Sales Manager / Marketing Manager |
Agilent (Group) |
Germany |
| Brutsche, Florian (UbiSim 202110 Co-Founder) |
Company Founder |
Labster (Group) |
Switzerland |
| Brübach, Amélie (Messe Stuttgart 201807 Head Communications Industry + Technology) |
public relations / investor relations |
Messe Stuttgart (Landesmesse Stuttgart GmbH) |
Germany |
| Brücher, Christoph |
n. a. |
Sanofi (Group) [since May 2011] |
Germany |
| Brück, Thomas (TU Munich 201604 Prof of Industrial Biocatalysis) |
Professor |
Technical University Munich (TU München, TUM) |
Germany |
| Brügemann, Lutz (Bruker 200905 Director RnD + Marketing) |
n. a. |
Bruker (Group) |
United States (USA) |
| Brüggemann, Andrea (Nanion Technologies GmbH 201102 Managing Director CSO) |
Managing Director |
Nanion (Group) |
Germany |
| Brüggen, Jochen |
n. a. |
PERSON |
|
| Brühlmann, Christian (Proteomedix 202001 COO/CFO) |
Chief Operating Officer (COO) |
Proteomedix AG |
Switzerland |
| Brümmer, Jens C. (Analytical Services North GmbH 2007) |
n. a. |
University of Hamburg |
Germany |
| Brüning, Kai (DEKA Investment 200601) |
n. a. |
Sparkassen-Finanzgruppe (DE) [FICTIVE UNIT, NOT OFFICIAL GROUP!] (Group) |
Germany |
| Brünker, Hans-Günter (Direvo Industrial Biotech 200807– before amaxa 200501) |
n. a. |
Lonza (Group) |
Germany |
| Brüstle, Oliver (Univ Bonn 200809 Prof) |
Professor |
University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn) |
Germany |
| Brzózka, Krzysztof (Selvita 201511 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Selvita (Group) |
Poland |
| Brändle, Frank (Identxx GmbH 201104 Managing Director) |
Managing Director |
Identxx GmbH |
Germany |
| Brändle, Martin (Tecan 201201 Head Corporate Communications + Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Tecan (Group) |
Switzerland |
| Bräuchle, Christoph |
n. a. |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
| Bräuer, Philipp (EQT 202210 Associate at EQT Life Sciences) |
Associate (venture capital) |
EQT (Wallenberg family) (Group) |
Netherlands |
| Bräuer, Uwe (Genius Venture Capital GmbH 201309 investment manager of Technologiefonds MV) |
Investment Manager |
Genius Venture Capital GmbH |
Germany |
| Bröcker, Rudolf (BRAIN 201507 Head Finance & Controlling) |
Controller (management) |
BRAIN Biotech (Group) |
Germany |
| Brönnimann, Christian (Dectris 201708 CEO) |
Chief Executive Officer (CEO) |
Dectris Ltd. (CH) |
Switzerland |
| Brönstrup, Mark (Helmholtz 201503 Prof + Head of Chemical Biology at HZI) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Buchanan, Iain (Noxxon 201009– interim CEO before Novexel CEO before Vertex Pharmaceuticals) |
Chief Executive Officer (CEO) |
Noxxon Pharma AG |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 8 9 10 ... 81 82 83 
![Picture [iito] Männer Ballett 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-maenner-ballett.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
